Literature DB >> 7959207

Chronic pancreatitis is associated with increased concentrations of epidermal growth factor receptor, transforming growth factor alpha, and phospholipase C gamma.

M Korc1, H Friess, Y Yamanaka, M S Kobrin, M Buchler, H G Beger.   

Abstract

The epidermal growth factor (EGF) receptor is a transmembrane protein that binds EGF and transforming growth factor alpha (TGF alpha), and that stimulates phospholipase C gamma 1 (PLC gamma 1) activity. In this study the role of the EGF receptor in chronic pancreatitis was studied. By immunohistochemistry, the EGF receptor, TGF alpha, and PLC gamma 1 were found to be expressed at high concentrations in pancreatic ductal and acinar cells from chronic pancreatitis patients. Northern blot analysis showed that, by comparison with normal controls, 19 of 27 chronic pancreatitis tissues exhibited a 5.7-fold increase in EGF receptor mRNA concentrations, and 20 of 27 chronic pancreatitis tissues exhibited a sixfold increase in TGF alpha mRNA concentrations. In situ hybridisation confirmed that overexpression occurred in ductal and acinar cells, and showed that both mRNA moieties colocalised with their respective proteins. These findings suggest that TGF alpha may act through autocrine and paracrine mechanisms to excessively activate the overexpressed EGF receptor in the two major cell types of the exocrine pancreas, thereby contributing to the pathobiology of this disorder.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7959207      PMCID: PMC1375027          DOI: 10.1136/gut.35.10.1468

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas.

Authors:  C L Arteaga; M D Johnson; G Todderud; R J Coffey; G Carpenter; D L Page
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

3.  Effects of dietary manganese deficiency on rat pancreatic amylase mRNA levels.

Authors:  S C Chang; P M Brannon; M Korc
Journal:  J Nutr       Date:  1990-10       Impact factor: 4.798

4.  Modulation of epidermal growth factor receptors in psoriatic lesions during treatment with topical EGF.

Authors:  L B Nanney; R A Yates; L E King
Journal:  J Invest Dermatol       Date:  1992-03       Impact factor: 8.551

5.  Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha.

Authors:  M Korc; B Chandrasekar; Y Yamanaka; H Friess; M Buchier; H G Beger
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

6.  Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group.

Authors:  A B Lowenfels; P Maisonneuve; G Cavallini; R W Ammann; P G Lankisch; J R Andersen; E P Dimagno; A Andrén-Sandberg; L Domellöf
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

7.  Role of rap1B and p21ras GTPase-activating protein in the regulation of phospholipase C-gamma 1 in human platelets.

Authors:  M Torti; E G Lapetina
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

8.  Cytological changes in the pancreas of transgenic mice overexpressing transforming growth factor alpha.

Authors:  D E Bockman; G Merlino
Journal:  Gastroenterology       Date:  1992-12       Impact factor: 22.682

9.  Pancreatic carcinoma developing in chronic pancreatitis: a report of four cases.

Authors:  O Haas; G Guillard; P Rat; S Friedman; J P Favre
Journal:  Hepatogastroenterology       Date:  1990-06

10.  Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.

Authors:  C M Barton; S L Staddon; C M Hughes; P A Hall; C O'Sullivan; G Klöppel; B Theis; R C Russell; J Neoptolemos; R C Williamson
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

View more
  24 in total

1.  The Beger procedure--duodenum-preserving pancreatic head resection.

Authors:  Hans G Beger; Rainer Kunz; Bertram Poch
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

Review 2.  The use of molecular technology in the differentiation of pancreatic cancer and chronic pancreatitis.

Authors:  S R Bramhall
Journal:  Int J Pancreatol       Date:  1998-04

3.  Overexpression of platelet-derived growth factor (PDGF) B chain and type beta PDGF receptor in human chronic pancreatitis.

Authors:  M Ebert; H U Kasper; S Hernberg; H Friess; M W Büchler; A Roessner; M Korc; P Malfertheiner
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

4.  Transgenic expression of cyclooxygenase-2 in pancreatic acinar cells induces chronic pancreatitis.

Authors:  Haojie Huang; Jiaxiang Chen; Lisi Peng; Yao Yao; Defeng Deng; Yang Zhang; Yan Liu; Huamin Wang; Zhaoshen Li; Yan Bi; Ashley N Haddock; Xianbao Zhan; Weiqin Lu; Craig D Logsdon; Baoan Ji
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-11-15       Impact factor: 4.052

Review 5.  β-Cell dysfunction in chronic pancreatitis.

Authors:  M Sasikala; R Talukdar; P Pavan kumar; G Radhika; G V Rao; R Pradeep; C Subramanyam; D Nageshwar Reddy
Journal:  Dig Dis Sci       Date:  2012-03-02       Impact factor: 3.199

6.  Overexpression of caspase-1 in pancreatic disorders: implications for a function besides apoptosis.

Authors:  M Ramadani; F Gansauge; S Schlosser; Y Yang; H G Beger; S Gansauge
Journal:  J Gastrointest Surg       Date:  2001 Jul-Aug       Impact factor: 3.452

7.  Induction of TFF1 gene expression in pancreas overexpressing transforming growth factor alpha.

Authors:  M P Ebert; J Hoffmann; C Haeckel; K Rutkowski; R M Schmid; M Wagner; G Adler; H U Schulz; A Roessner; W Hoffmann; P Malfertheiner
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

8.  EGF receptor is required for KRAS-induced pancreatic tumorigenesis.

Authors:  Christine M Ardito; Barbara M Grüner; Kenneth K Takeuchi; Clara Lubeseder-Martellato; Nicole Teichmann; Pawel K Mazur; Kathleen E Delgiorno; Eileen S Carpenter; Christopher J Halbrook; Jason C Hall; Debjani Pal; Thomas Briel; Alexander Herner; Marija Trajkovic-Arsic; Bence Sipos; Geou-Yarh Liou; Peter Storz; Nicole R Murray; David W Threadgill; Maria Sibilia; M Kay Washington; Carole L Wilson; Roland M Schmid; Elaine W Raines; Howard C Crawford; Jens T Siveke
Journal:  Cancer Cell       Date:  2012-09-11       Impact factor: 31.743

9.  Overexpression of Caspase-1 in adenocarcinoma of pancreas and chronic pancreatitis.

Authors:  Yin-Mo Yang; Marco Ramadani; Yan-Ting Huang
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

Review 10.  Mechanisms of resistance to EGFR targeted therapies.

Authors:  Gorjan Hrustanovic; Bianca J Lee; Trever G Bivona
Journal:  Cancer Biol Ther       Date:  2013-01-28       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.